Clinical Research; Lipid Replacement technology introduction

SUPPORTING SCIENCE

The publications in this section are science and medical literature reviews that support the role Propax with NT Factor® can provide for people.

Because people will primarily use Propax to improve quality of life under virtually any circumstance there are many simultaneously occurring situations such as disease management.

The papers in this section are intended to provide confidence and information for the health practitioner and the consumer that Propax w/ NT Factor is safe and non-interfering with any community standard of care therapy.

PUBLISHED PAPER DESCRIPTION OF PAPER
Blaylock R.L., A Review of Conventional Cancer Prevention and Treatment and the Adjunctive Use of Nutraceutical Supplements and Antioxidants. JANA. 2000; 3(3): 17-35
With the increasing popularity of alternative methods of disease treatment, much controversy has arisen over the safety of administering antioxidants to patients undergoing conventional chemotherapy and radiation treatments for cancer. Oncologist have voiced concern over the possible negating effect of antioxidants on the therapeutic effectiveness of these treatments, since they depend, for the most part, on free radical generation within tumor cells for their tumoricidal effect. Is this a concern supported by scientific evidence or clinical experience? The answer appears to be “no”, when properly designed antioxidant programs are used, and as we shall see, they may actually enhance the effectiveness of both chemotherapy and radiation treatments
Block J.R., Evans S., Clinical Evidence Supporting Cancer Risk Reduction with Antioxidants andImplications for Diet and Supplementation. JANA. 2000; 3(3): 6-16
Within the context of the debate and continuum introduced at the onset of this article, we conclude that there is sufficient pertinent scientific clinical data to indicate that certain antioxidant and other nutrient supplements reduce cancer risk, clinical cancer occurrence, and/or interrupt usefully the carcinogenic process in appropriately defined populations. In concert, dietary supplements may be a necessary and useful complement to a diet-based strategy, and are likely to be necessary for a growing segment of the US. population to achieve efficacious consequences in cancer prevention.
Block JR, Evans S. A Review of Recent ResultsAddressing the Potential Interactions of Antioxidants with Cancer Drug Therapy, JANA. 2001; 4(1): 11-19
Hypotheses that antioxidants’ inhibition of free-radical activity may negate cytotoxic properties of some cancer therapies have been dependent on naive and inaccurate assumptions. The available data suggest a rational basis for the continued use of selected antioxidant agents as therapeutic adjuncts in cancer therapy, with such use also offering a potential to abrogate the carcinogenic process and mutation-driven drug resistance, but convincing data and widespread acceptance of such a role is dependent on additional, appropriately relevant trials.
Friedrich J., Protective And Normalizing Benefits Of Soy:Clinical Considerations, Monograph Nutritional Therapeutics, Inc., Hauppauge NY 1998
Literature review of the foods and food extracts in NT Factor®.
Harris M., The Soybean's Polyunsaturated Phosphatidyl Choline: The Pivotal Substance for Optimal Cellular Function, Nutritional Therapeutics, Inc., Hauppauge NY 2000
An essay providing a brief synopsis of the purified oils used in NT Factor®.

The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any pharmaceutical product without first consulting your prescribing physician.